Full-Time

Assistant Vice President Governance, Risk & Compliance

Deadline 9/2/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

No salary listed

Company Historically Provides H1B Sponsorship

California, USA

Remote

Bachelor's, Master's, MBA, JD

Category
Legal & Compliance (1)
Required Skills
SOC 2
Risk Management
HIPAA

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • A bachelor's degree in Information Security, Computer Science, Risk Management, or a related field, or equivalent professional experience.
  • At least 10 years of progressive experience in information security, information technology risk management, or regulatory compliance, including at least 5 years in a leadership role.
  • Deep working knowledge of HITRUST CSF, SOX information technology general controls, SOC 1/SOC 2, NIST CSF, ISO 27001, and related cybersecurity control frameworks.
  • Experience building or scaling an enterprise governance, risk, and compliance program, including risk assessment and policy management.
  • Hands-on experience with governance, risk, and compliance platforms and risk quantification/reporting tools, including automation and evidence reuse capabilities.
  • Experience communicating risk and compliance matters to executive leadership, Board committees, auditors, and regulators.
  • Executive presence and the ability to influence senior leaders, represent the governance, risk, and compliance function in executive forums, and communicate complex risk and compliance matters clearly and credibly.
  • Experience partnering with Internal Audit and managing external regulatory examinations.
  • Experience supporting SOX control testing, SOC readiness or attestation activities, audit evidence collection, control deficiency remediation, and executive-level reporting on compliance posture.
  • Experience operating within a matrixed, multi-business-unit enterprise.
  • Ability to lead through influence and build trusted relationships across business leaders, technology teams, Legal, Finance, Internal Audit, regulators, external auditors, consultants, and third-party service providers.
  • Enterprise people leadership and talent management experience, including building, developing, coaching, and retaining high-performing teams; cultivating succession bench strength; and leading leaders through organizational change.
Responsibilities
  • Lead the development and execution of the enterprise information security governance, risk, technology compliance, and regulatory compliance strategy.
  • Drive the cybersecurity risk assessment program, including risk identification, quantification, tracking, remediation, and risk posture reporting.
  • Lead modernization and automation of governance, risk, and compliance capabilities, including evidence reuse, automated control testing, and AI-assisted risk quantification and reporting.
  • Ensure compliance with applicable healthcare cybersecurity regulatory and industry requirements, including HIPAA, HITECH, 42 CFR Part 2, CMS security and privacy requirements, FDA requirements, state insurance and privacy laws, PCI DSS, SOX, SOC 1/SOC 2, and SEC cybersecurity disclosure requirements.
  • Own enterprise technology compliance for cybersecurity, ensuring technology controls, configurations, and platforms meet applicable regulatory, contractual, and internal policy requirements.
  • Direct the lifecycle of enterprise information security policies, standards, and procedures, aligning them to NIST CSF, ISO 27001, HITRUST CSF, and other adopted control frameworks.
  • Serve as the primary governance, risk, and compliance liaison to Internal Audit, external auditors, and regulators; coordinate audit and examination responses and remediation of findings.
  • Oversee SOX cybersecurity and information technology general control support, including control scoping, evidence validation, deficiency tracking, and remediation.
  • Lead SOC 1 and SOC 2 readiness and attestation support, including control mapping, evidence management, audit coordination, exception handling, and continuous improvement of trust services control coverage.
  • Own the security exception and risk acceptance process, ensuring executive visibility and accountability for accepted risk.
  • Establish and lead enterprise AI risk governance, including oversight of AI-related security, privacy, and regulatory risk.
  • Partner with Security Risk Management leadership to align the enterprise risk framework, control taxonomy, and reporting with the vendor risk program.
  • Build partnerships with internal and external stakeholders to strengthen alignment, resolve issues, and advance enterprise risk and compliance objectives.
  • Prepare and deliver cybersecurity risk posture reporting to the Board Risk/Audit Committee and other executive governance forums.
  • Manage and mature governance, risk, and compliance tooling and platforms for risk quantification, control testing, and reporting automation.
  • Lead and develop the governance, risk, and compliance team, building succession bench strength and fostering accountability, continuous improvement, business partnership, and effective change leadership.
Desired Qualifications
  • An advanced degree, such as an MBA or MS in a related discipline, or a JD with a cybersecurity and risk focus.
  • Relevant certifications such as CISSP, CISM, CISA, CRISC, or CIPP.
  • Experience in healthcare, pharmacy, health insurance, or retail industries.
  • Experience with AI governance, model risk management, or emerging AI regulation.
  • Familiarity with SEC cybersecurity disclosure requirements and materiality assessment processes.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.